FDA Accepts Richter’s Marketing Authorization for Denosumab Biosimilars
The U.S. Food and Drug Administration (FDA) has accepted the application submitted by Gedeon Richter and Hikma for the approval of denosumab biosimilars (affordable versions of osteoporosis drugs, mimicking its safety and efficacy), Richter announced on …